All In MedTech

Device Trial Radar · NCT06248216

Virtual Reality Therapy for Cancer-Treatment Associated Symptoms

Implementation of an At-Home Multimodal Integrative Therapy Via Virtual Reality for Patients With Cancer-Treatment Associated Symptoms

Last checked: Nov 19, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Dec 4, 2024

Primary completion

Apr 2027

Study completion Dec 2027

Sponsor

Lead sponsor
University of Maryland, BaltimoreAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 8, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Triple (care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 88 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.

Conditions

  • Cancer
  • Cancer Pain
  • Virtual Reality

Interventions

  • RelievrxDevice

    The RelieVRx program is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.

  • Audio Mp4Other

    Audio Mp4 modules ranging from 3-15 minutes with guided meditation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. VR effect on perceived painTime frame: Baseline to end of intervention (4 weeks)
  2. VR effect on perceived fatigueTime frame: Baseline to end of intervention (4 weeks)
  3. VR effect on perceived anxietyTime frame: Baseline to end of intervention (4 weeks)

9 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Luana Colloca

    Baltimore, Maryland · Recruiting

  • University of Maryland

    Baltimore, Maryland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.